JMI LABS IS NOW PART OF LEARN MORE

TR-700, a Novel Oxazolidinone, Tested Against Linezolid-Resistant Gram-positive Species with Well-Characterized Resistance Mechanisms, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

View publication